Clinical Trial Update: Anti-Oxidant Treatment of Alzheimer's Disease [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating an antioxidant treatment for Alzheimer's disease has completed. The study was sponsored by the National Institute on Aging (…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: National Institute on Aging (NIA) | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED